Rafael De Cid1, Rabah Ben Yaou1, Carinne Roudaut1, Karine Charton1, Sylvain Baulande1, France Leturcq1, Norma Beatriz Romero1, Edoardo Malfatti1, Maud Beuvin1, Anna Vihola1, Audrey Criqui1, Isabelle Nelson1, Juliette Nectoux1, Laurène Ben Aim1, Christophe Caloustian1, Robert Olaso1, Bjarne Udd1, Gisèle Bonne1, Bruno Eymard1, Isabelle Richard2. 1. From INSERM (R.D.C., C.R., K.C., I.R.), U951; Généthon (R.D.C., C.R., K.C., I.R.), R&D Department, INTEGRARE Research Unit, Evry; Neuromuscular Morphology Unit, Myology Institute (N.B.R., M.B.), and INSERM UMRS_974, CNRS FRE 3617, Center of Research in Myology (R.B.Y., F.L., N.B.R., E.M., M.B., I.N., G.B.), Sorbonne Universités, UPMC Univ Paris 06, and AP-HP, University Hospital, Reference Center for Neuromuscular Diseases, Myology Institute (R.B.Y., N.B.R., E.M., B.E.), Groupe Hospitalier La Pitié-Salpêtrière, Paris; Génopole Campus 2 (S.B., A.C.), PartnerChip, Evry; the Department of Medical Genetics (F.L., A.V., B.U.), Folkhälsan Institute of Genetics, University of Helsinki, Finland; AP-HP (J.N.), Groupe Hospitalier Cochin-Broca-Hôtel Dieu, Laboratoire de Biochimie et Génétique Moléculaire, Paris; CEA-IG-Centre National de Genotypage (L.B.A., C.C., R.O.), Evry; Neuromuscular Research Center (B.U.), Tampere University Hospital and University of Tampere, Finland; and the Department of Neurology (B.U.), Vaasa Central Hospital, Finland. R.D.C. is currently affiliated with Disease Genomics Group, Institut de Medicina Predictiva i Personalitzada del Càncer, Campus de Can Ruti, Camí de les Escoles, Badalona (Barcelona), Spain. 2. From INSERM (R.D.C., C.R., K.C., I.R.), U951; Généthon (R.D.C., C.R., K.C., I.R.), R&D Department, INTEGRARE Research Unit, Evry; Neuromuscular Morphology Unit, Myology Institute (N.B.R., M.B.), and INSERM UMRS_974, CNRS FRE 3617, Center of Research in Myology (R.B.Y., F.L., N.B.R., E.M., M.B., I.N., G.B.), Sorbonne Universités, UPMC Univ Paris 06, and AP-HP, University Hospital, Reference Center for Neuromuscular Diseases, Myology Institute (R.B.Y., N.B.R., E.M., B.E.), Groupe Hospitalier La Pitié-Salpêtrière, Paris; Génopole Campus 2 (S.B., A.C.), PartnerChip, Evry; the Department of Medical Genetics (F.L., A.V., B.U.), Folkhälsan Institute of Genetics, University of Helsinki, Finland; AP-HP (J.N.), Groupe Hospitalier Cochin-Broca-Hôtel Dieu, Laboratoire de Biochimie et Génétique Moléculaire, Paris; CEA-IG-Centre National de Genotypage (L.B.A., C.C., R.O.), Evry; Neuromuscular Research Center (B.U.), Tampere University Hospital and University of Tampere, Finland; and the Department of Neurology (B.U.), Vaasa Central Hospital, Finland. R.D.C. is currently affiliated with Disease Genomics Group, Institut de Medicina Predictiva i Personalitzada del Càncer, Campus de Can Ruti, Camí de les Escoles, Badalona (Barcelona), Spain. richard@genethon.fr.
Abstract
OBJECTIVE: To identify the genetic defects present in 3 families with muscular dystrophy, contractures, and calpain 3 deficiency. METHODS: We performed targeted exome sequencing on one patient presenting a deficiency in calpain 3 on Western blot but for which mutations in the gene had been excluded. The identification of a homozygous truncating mutation in the M-line part of titin prompted us to sequence this region in 2 additional patients presenting similar clinical and biochemical characteristics. RESULTS: The 3 patients shared similar features: coexistence of limb-girdle weakness and early-onset diffuse joint contractures without cardiomyopathy. The biopsies showed rimmed vacuoles, a dystrophic pattern, and secondary reduction in calpain 3. We identified a novel homozygous mutation in the exon Mex3 of the TTN gene in the first patient. At protein level, this mutation introduces a stop codon at the level of Mex3. Interestingly, we identified truncating mutations in both alleles in the same region of the TTN gene in patients from 2 additional families. Molecular protein analyses confirm loss of the C-ter part of titin. CONCLUSIONS: Our study broadens the phenotype of titinopathies with the report of a new clinical entity with prominent contractures and no cardiac abnormality and where the recessive mutations lead to truncation of the M-line titin and secondary calpain 3 deficiency.
OBJECTIVE: To identify the genetic defects present in 3 families with muscular dystrophy, contractures, and calpain 3 deficiency. METHODS: We performed targeted exome sequencing on one patient presenting a deficiency in calpain 3 on Western blot but for which mutations in the gene had been excluded. The identification of a homozygous truncating mutation in the M-line part of titin prompted us to sequence this region in 2 additional patients presenting similar clinical and biochemical characteristics. RESULTS: The 3 patients shared similar features: coexistence of limb-girdle weakness and early-onset diffuse joint contractures without cardiomyopathy. The biopsies showed rimmed vacuoles, a dystrophic pattern, and secondary reduction in calpain 3. We identified a novel homozygous mutation in the exon Mex3 of the TTN gene in the first patient. At protein level, this mutation introduces a stop codon at the level of Mex3. Interestingly, we identified truncating mutations in both alleles in the same region of the TTN gene in patients from 2 additional families. Molecular protein analyses confirm loss of the C-ter part of titin. CONCLUSIONS: Our study broadens the phenotype of titinopathies with the report of a new clinical entity with prominent contractures and no cardiac abnormality and where the recessive mutations lead to truncation of the M-line titin and secondary calpain 3 deficiency.
Authors: Yael Peled; Michael Gramlich; Guy Yoskovitz; Micha S Feinberg; Arnon Afek; Sylvie Polak-Charcon; Elon Pras; Ben-Ami Sela; Eli Konen; Omer Weissbrod; Dan Geiger; Paul M K Gordon; Ludwig Thierfelder; Dov Freimark; Brenda Gerull; Michael Arad Journal: Int J Cardiol Date: 2013-11-25 Impact factor: 4.164
Authors: Ozge Ceyhan-Birsoy; Pankaj B Agrawal; Carlos Hidalgo; Klaus Schmitz-Abe; Elizabeth T DeChene; Lindsay C Swanson; Rachel Soemedi; Nasim Vasli; Susan T Iannaccone; Perry B Shieh; Natasha Shur; Jane M Dennison; Michael W Lawlor; Jocelyn Laporte; Kyriacos Markianos; William G Fairbrother; Henk Granzier; Alan H Beggs Journal: Neurology Date: 2013-08-23 Impact factor: 9.910
Authors: Claire Chauveau; Carsten G Bonnemann; Cedric Julien; Ay Lin Kho; Harold Marks; Beril Talim; Philippe Maury; Marie Christine Arne-Bes; Emmanuelle Uro-Coste; Alexander Alexandrovich; Anna Vihola; Sebastian Schafer; Beth Kaufmann; Livija Medne; Norbert Hübner; A Reghan Foley; Mariarita Santi; Bjarne Udd; Haluk Topaloglu; Steven A Moore; Michael Gotthardt; Mark E Samuels; Mathias Gautel; Ana Ferreiro Journal: Hum Mol Genet Date: 2013-10-08 Impact factor: 6.150
Authors: Gerald Pfeffer; Hannah R Elliott; Helen Griffin; Rita Barresi; James Miller; Julie Marsh; Anni Evilä; Anna Vihola; Peter Hackman; Volker Straub; David J Dick; Rita Horvath; Mauro Santibanez-Koref; Bjarne Udd; Patrick F Chinnery Journal: Brain Date: 2012-05-09 Impact factor: 13.501
Authors: Marco Savarese; Lorenzo Maggi; Anna Vihola; Per Harald Jonson; Giorgio Tasca; Lucia Ruggiero; Luca Bello; Francesca Magri; Teresa Giugliano; Annalaura Torella; Anni Evilä; Giuseppina Di Fruscio; Olivier Vanakker; Sara Gibertini; Liliana Vercelli; Alessandra Ruggieri; Carlo Antozzi; Helena Luque; Sandra Janssens; Maria Barbara Pasanisi; Chiara Fiorillo; Monika Raimondi; Manuela Ergoli; Luisa Politano; Claudio Bruno; Anna Rubegni; Marika Pane; Filippo M Santorelli; Carlo Minetti; Corrado Angelini; Jan De Bleecker; Maurizio Moggio; Tiziana Mongini; Giacomo Pietro Comi; Lucio Santoro; Eugenio Mercuri; Elena Pegoraro; Marina Mora; Peter Hackman; Bjarne Udd; Vincenzo Nigro Journal: JAMA Neurol Date: 2018-05-01 Impact factor: 18.302
Authors: Heinz Jungbluth; Mathias Gautel; Martin Rees; Roksana Nikoopour; Atsushi Fukuzawa; Ay Lin Kho; Miguel A Fernandez-Garcia; Elizabeth Wraige; Istvan Bodi; Charu Deshpande; Özkan Özdemir; Hülya-Sevcan Daimagüler; Mark Pfuhl; Mark Holt; Birgit Brandmeier; Sarah Grover; Joël Fluss; Cheryl Longman; Maria Elena Farrugia; Emma Matthews; Michael Hanna; Francesco Muntoni; Anna Sarkozy; Rahul Phadke; Ros Quinlivan; Emily C Oates; Rolf Schröder; Christian Thiel; Jens Reimann; Nicol Voermans; Corrie Erasmus; Erik-Jan Kamsteeg; Chaminda Konersman; Carla Grosmann; Shane McKee; Sandya Tirupathi; Steven A Moore; Ekkehard Wilichowski; Elke Hobbiebrunken; Gabriele Dekomien; Isabelle Richard; Peter Van den Bergh; Cristina Domínguez-González; Sebahattin Cirak; Ana Ferreiro Journal: Acta Neuropathol Date: 2021-01-15 Impact factor: 17.088
Authors: Emily C Oates; Kristi J Jones; Sandra Donkervoort; Amanda Charlton; Susan Brammah; John E Smith; James S Ware; Kyle S Yau; Lindsay C Swanson; Nicola Whiffin; Anthony J Peduto; Adam Bournazos; Leigh B Waddell; Michelle A Farrar; Hugo A Sampaio; Hooi Ling Teoh; Phillipa J Lamont; David Mowat; Robin B Fitzsimons; Alastair J Corbett; Monique M Ryan; Gina L O'Grady; Sarah A Sandaradura; Roula Ghaoui; Himanshu Joshi; Jamie L Marshall; Melinda A Nolan; Simranpreet Kaur; Jaya Punetha; Ana Töpf; Elizabeth Harris; Madhura Bakshi; Casie A Genetti; Minttu Marttila; Ulla Werlauff; Nathalie Streichenberger; Alan Pestronk; Ingrid Mazanti; Jason R Pinner; Carole Vuillerot; Carla Grosmann; Ana Camacho; Payam Mohassel; Meganne E Leach; A Reghan Foley; Diana Bharucha-Goebel; James Collins; Anne M Connolly; Heather R Gilbreath; Susan T Iannaccone; Diana Castro; Beryl B Cummings; Richard I Webster; Leïla Lazaro; John Vissing; Sandra Coppens; Nicolas Deconinck; Ho-Ming Luk; Neil H Thomas; Nicola C Foulds; Marjorie A Illingworth; Sian Ellard; Catriona A McLean; Rahul Phadke; Gianina Ravenscroft; Nanna Witting; Peter Hackman; Isabelle Richard; Sandra T Cooper; Erik-Jan Kamsteeg; Eric P Hoffman; Kate Bushby; Volker Straub; Bjarne Udd; Ana Ferreiro; Kathryn N North; Nigel F Clarke; Monkol Lek; Alan H Beggs; Carsten G Bönnemann; Daniel G MacArthur; Henk Granzier; Mark R Davis; Nigel G Laing Journal: Ann Neurol Date: 2018-06 Impact factor: 10.422